Archives
-
Bestatin-Derived Inhibitors of IRAP and ERAP1
2026-09-04
The reference study develops a stereoselective route for functionalizing Bestatin’s α-hydroxy-β-amino acid scaffold and applies structural biology to improve inhibitor potency and selectivity. Its most important result is a cell-active, low-nanomolar IRAP inhibitor with more than 120-fold selectivity over homologous aminopeptidases, while X-ray structures identify GAMEN-loop interactions as an underappreciated determinant of recognition.
-
15-PGDH Inhibition Supports Muscle Recovery
2026-09-04
A 2026 PNAS study shows that inhibiting 15-PGDH can improve muscle stem cell activity, regenerated myofiber growth, and force recovery during semaglutide-associated weight loss in obese mice. The work suggests that combining a 15-PGDH inhibitor with a GLP-1 receptor agonist may preserve regenerative muscle quality without weakening weight-loss efficacy.
-
U0126-EtOH: Translational MEK/ERK Strategy
2026-09-03
U0126-EtOH is a selective MEK1/2 inhibitor for testing causal MAPK/ERK signaling in neuronal, inflammatory, and cancer research. This thought-leadership guide connects mechanism, protocol design, model selection, and translational decision-making beyond a conventional product overview.
-
Tacalcitol Monohydrate: Applied Research Workflows
2026-09-03
Tacalcitol monohydrate connects VDR-driven keratinocyte biology with practical NGF and colorectal cancer assays. This guide translates published concentrations, timing, formulation, and troubleshooting considerations into reproducible workflows for dermatology and oncology research.
-
Stem Cell Screens That Measure Biology, Not Just Death
2026-09-02
High-content screening becomes more translational when it quantifies cell-state mechanisms rather than relying on viability alone. A 280-compound parasite stem-cell study illustrates how DiscoveryProbe™ Stem Cell Compound Library Plus can connect pathway coverage, phenotypic imaging, and orthogonal validation while clarifying the limits of cross-domain evidence.
-
(+)-Bicuculline: Practical Workflow Guide
2026-09-02
(+)-Bicuculline is a research-use GABAA receptor antagonist for controlled studies of inhibitory neurotransmission, synaptic NMDA receptor signaling modulation, and related neuronal endpoints. This guide focuses on solvent selection, stock preparation, storage, controls, and interpretation; the compound is not intended for diagnostic, therapeutic, or clinical use.
-
MTT Assays: Reading Metabolism, Not Just Viability
2026-09-01
Discover how MTT converts intracellular redox activity into a practical readout for proliferation and cytotoxicity studies. This article shows how to interpret MTT results more rigorously in redox-active nanomedicine and glioblastoma research.
-
7-Ethyl-10-hydroxycamptothecin in Cell Assays
2026-09-01
A scenario-based guide to using 7-Ethyl-10-hydroxycamptothecin (SN-38, SKU N2133) in viability, proliferation, cytotoxicity, apoptosis, and cell-cycle studies. It connects mechanism, solvent compatibility, assay design, interpretation, and practical supplier selection to improve experimental consistency.
-
Coumestrol, PMAIP1, and Ferroptosis in RA-FLS
2026-08-31
The reference study identifies a mechanistic link between Coumestrol, TRIM3-dependent protein turnover, mitochondrial PMAIP1 stability, and ferroptosis in rheumatoid arthritis fibroblast-like synoviocytes. Its findings suggest that redirecting the survival state of RA-FLS may suppress both pathological proliferation and inflammatory cytokine production, while also highlighting important limits for translation beyond the cell model.
-
AZD3463: Designing Better ALK Dependency Assays
2026-08-31
AZD3463 is an ALK/IGF1R inhibitor for dissecting oncogenic signaling in neuroblastoma models. This article presents a lineage-aware assay strategy, connects pathway measurements with phenotype, and explains how chemically defined stem-cell methods can improve experimental reproducibility without overstating cross-domain evidence.
-
Red Blood Cell Lysis Buffer: Workflow Guide
2026-08-30
Build cleaner blood sample preparation workflows with selective erythrocyte removal, practical starting conditions, and assay-specific recovery checks. This guide connects flow cytometry and molecular workflows with a carefully bounded application of osteoblast research insights.
-
Atorvastatin: Mechanism and Research Evidence
2026-08-29
Atorvastatin is an orally bioavailable HMG-CoA reductase inhibitor used in cholesterol metabolism research, vascular cell biology studies, and cardiovascular disease research. Product data support defined cell and animal benchmarks, while a 2025 peer-reviewed study identifies atorvastatin as a potential ferroptosis-inducing agent in hepatocellular carcinoma models.
-
RIPA Lysis Buffer (Strong) for Enteric Neuron Studies
2026-08-28
RIPA Lysis Buffer (Strong) enables high-yield protein extraction from macrophages, enteric neurons, and intestinal tissues for pathway-focused immunoblotting and validation. This practical workflow shows how to preserve MMP8–TGF-β signaling evidence while avoiding detergent-related problems in exosome and immunoprecipitation experiments.
-
Ketamine, Immune Regulation, and Depressive-Like Behavior
2026-08-28
A 2025 Molecular Psychiatry study links ketamine’s behavioral effects in an LPS-induced mouse model to coordinated changes in microglia, infiltrating monocytes, neutrophils, splenic lymphocytes, and macrophage polarization. The work supports an integrated neuroimmune mechanism while showing why behavioral rescue alone is insufficient to establish antidepressant causality.
-
AAL-993 in VEGF Receptor Inhibitor Workflows
2026-08-27
AAL-993 provides a selective way to interrogate VEGFR-driven endothelial signaling, tumor angiogenesis, and metastatic behavior across biochemical, cellular, and mouse models. Its strong VEGFR-2 and VEGFR-3 activity makes it especially useful for mechanism-led anti-angiogenic workflows, while careful formulation and pathway controls improve reproducibility.